Author

Amie Tan

Observed name: Amie Ruoding Tan

Observed institution: Genentech

OpenAlex ID: A5075230015

Real-World Experiences Using Atezolizumab + Bevacizumab for the Treatment of Unresectable Hepatocellular Carcinoma: A Multicenter Study

2025 · Maen Abdelrahim, Abdullah Esmail, et al. · Cancers · 7

PDF

Real-world (RW) experience with atezolizumab + bevacizumab (A+B) for the treatment of unresectable HCC (uHCC): A multicenter study.

2025 · Maen Abdelrahim, Abdullah Esmail, et al. · Journal of Clinical Oncology · 3

Real-world clinical and economic burden associated with hospitalization in metastatic triple-negative (ER-/PR-/HER2-) breast cancer.

2020 · Amie Tan, Xu Han, et al. · Journal of Clinical Oncology · 2

Prognostic significance of real-world (RW) recurrence patterns after resection or ablation of early-stage hepatocellular carcinoma (HCC): Insights from the US Medicare population.

2024 · Shishir K. Maithel, Rongrong Wang, et al. · Journal of Clinical Oncology · 1

PDF

Atezolizumab plus bevacizumab (A+B) in patients with unresectable hepatocellular carcinoma (uHCC): Real-world experience from a US community oncology network.

2024 · David Cosgrove, Amie Tan, et al. · Journal of Clinical Oncology · 1

Comparing first-line (1L) atezolizumab plus bevacizumab (A+B) to lenvatinib (L) or sorafenib (S) in patients with unresectable hepatocellular carcinoma (uHCC): Findings from the National Veteran Health Administration (VHA) database.

2024 · David Edward Kaplan, Amie Tan, et al. · Journal of Clinical Oncology · 1

PDF

Survival by race and ethnicity among insured patients with early-onset colorectal cancer.

2024 · Jeffrey Lee, Christopher Jensen, et al. · Journal of Clinical Oncology · 1

Improving patient self-management in hepatocellular carcinoma using care sequence plans: A comparative survey study.

2026 · Maen Abdelrahim, Abdullah Esmail, et al. · Journal of Clinical Oncology

PDF

Intervention to improve care delivery and patient self-management for people with primary liver cancer who have socioeconomic disadvantages.

2024 · Christine B. Weldon, Jonathan Mizrahi, et al. · Journal of Clinical Oncology

Care delivery and patient self-management for people with primary liver cancer receiving 4R care sequence plans.

2024 · George Therapondos, Christine B. Weldon, et al. · Journal of Clinical Oncology

Racial/ethnic disparities in the effectiveness of atezolizumab plus bevacizumab (A+B) vs. tyrosine kinase inhibitors (TKIs) among veterans with unresectable hepatocellular carcinoma (uHCC).

2024 · David Edward Kaplan, Amie Tan, et al. · Journal of Clinical Oncology

PDF

Gaps in care planning and delivery for patients with liver cancer: Baseline assessment for implementation of 4R Oncology model.

2023 · George Therapondos, Julia R. Trosman, et al. · JCO Oncology Practice

PDF

Real-world (RW) treatment and surveillance patterns in patients with hepatocellular carcinoma (HCC) after resection (R) or ablation (A): Evidence from commercial and Medicare populations.

2023 · Amie Tan, Robert Schuldt, et al. · Journal of Clinical Oncology

PDF

Gaps in care planning and delivery for patients with liver cancer: Baseline assessment for implementation of 4R Oncology model.

2023 · George Therapondos, Julia R. Trosman, et al. · Journal of Clinical Oncology

Underutilization of Treatments for Hepatocellular Carcinoma (HCC) in Medicare Population/ Geographic Disparity and Association with Social Determinants of Health

2023 · Amie Ruoding Tan, Neto Coulibaly, et al. · International Journal of Cancer Care and Delivery

PDF

Impact of race/ethnicity and socioeconomic status on emergency department visits in patients with hepatocellular carcinoma.

2022 · Daniel Lin, Amie Tan, et al. · Journal of Clinical Oncology

Abstract PS7-23: Neoadjuvant and adjuvant therapy (NAT/AT) treatment patterns and clinical characteristics in a real-world cohort of US patients with HR+/HER2− early breast cancer (eBC)

2021 · Mary K Downer, Christopher Craggs, et al. · Cancer Research

Abstract PS7-53: Assessing racial differences in patients with metastatic triple-negative breast cancer: Real-world evidence from US community oncology practices

2021 · Amie Tan, Vincent Shen, et al. · Cancer Research

Works count: 18

Citation count: 16

H-index: 2

I10-index: